Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan A Burger

Showing results (91-100 of 223) with videos related to

Pageof 23
Sort By:
Blood|May 6, 2010
Influence of bone marrow stromal microenvironment on forodesine-induced responses in CLL primary cellsKumudha Balakrishnan, Jan A Burger, Maite P Quiroga, et al.
Blood|December 17, 2008
High-level expression of the T-cell chemokines CCL3 and CCL4 by chronic lymphocytic leukemia B cells in nurselike cell cocultures and after BCR stimulationJan A Burger, Maite P Quiroga, Elena Hartmann, et al.
Blood|November 27, 2013
The Spiegelmer NOX-A12, a novel CXCL12 inhibitor, interferes with chronic lymphocytic leukemia cell motility and causes chemosensitizationJulia Hoellenriegel, Dirk Zboralski, Christian Maasch, et al.
Oncogene|November 7, 2003
Functional expression of CXCR4 (CD184) on small-cell lung cancer cells mediates migration, integrin activation, and adhesion to stromal cellsMeike Burger, Aleksandra Glodek, Tanja Hartmann, et al.
Haematologica|August 12, 2017
Consolidation treatment with lenalidomide following front-line or salvage chemoimmunotherapy in chronic lymphocytic leukemiaPaolo Strati, Michael J Keating, Jan A Burger, et al.
Leukemia Research|February 21, 2021
Impact of long-term ibrutinib treatment on circulating immune cells in previously untreated chronic lymphocytic leukemiaIsabelle G Solman, Lisa K Blum, Jan A Burger, et al.
Blood|September 14, 2021
Ibrutinib induces durable remissions in treatment-naïve patients with CLL and 17p deletion and/or TP53 mutationsMariela Sivina, Ekaterina Kim, William G Wierda, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 9, 2010
The great imitator: systemic nocardiosis mimicking Richter's transformation in relapsed chronic lymphocytic leukemiaSameer A Parikh, Yogesh Bhusal, Stefan H Faderl, et al.
Blood|June 4, 2009
B-cell antigen receptor signaling enhances chronic lymphocytic leukemia cell migration and survival: specific targeting with a novel spleen tyrosine kinase inhibitor, R406Maite P Quiroga, Kumudha Balakrishnan, Antonina V Kurtova, et al.
Blood|December 30, 2016
Ibrutinib inhibits pre-BCR<sup>+</sup> B-cell acute lymphoblastic leukemia progression by targeting BTK and BLKEkaterina Kim, Christian Hurtz, Stefan Koehrer, et al.
Pageof 23

Showing results (91-100 of 223) with videos related to

Sort By:
Pageof 23
Blood|May 6, 2010
Influence of bone marrow stromal microenvironment on forodesine-induced responses in CLL primary cellsKumudha Balakrishnan, Jan A Burger, Maite P Quiroga, et al.
Blood|December 17, 2008
High-level expression of the T-cell chemokines CCL3 and CCL4 by chronic lymphocytic leukemia B cells in nurselike cell cocultures and after BCR stimulationJan A Burger, Maite P Quiroga, Elena Hartmann, et al.
Blood|November 27, 2013
The Spiegelmer NOX-A12, a novel CXCL12 inhibitor, interferes with chronic lymphocytic leukemia cell motility and causes chemosensitizationJulia Hoellenriegel, Dirk Zboralski, Christian Maasch, et al.
Oncogene|November 7, 2003
Functional expression of CXCR4 (CD184) on small-cell lung cancer cells mediates migration, integrin activation, and adhesion to stromal cellsMeike Burger, Aleksandra Glodek, Tanja Hartmann, et al.
Haematologica|August 12, 2017
Consolidation treatment with lenalidomide following front-line or salvage chemoimmunotherapy in chronic lymphocytic leukemiaPaolo Strati, Michael J Keating, Jan A Burger, et al.
Leukemia Research|February 21, 2021
Impact of long-term ibrutinib treatment on circulating immune cells in previously untreated chronic lymphocytic leukemiaIsabelle G Solman, Lisa K Blum, Jan A Burger, et al.
Blood|September 14, 2021
Ibrutinib induces durable remissions in treatment-naïve patients with CLL and 17p deletion and/or TP53 mutationsMariela Sivina, Ekaterina Kim, William G Wierda, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 9, 2010
The great imitator: systemic nocardiosis mimicking Richter's transformation in relapsed chronic lymphocytic leukemiaSameer A Parikh, Yogesh Bhusal, Stefan H Faderl, et al.
Blood|June 4, 2009
B-cell antigen receptor signaling enhances chronic lymphocytic leukemia cell migration and survival: specific targeting with a novel spleen tyrosine kinase inhibitor, R406Maite P Quiroga, Kumudha Balakrishnan, Antonina V Kurtova, et al.
Blood|December 30, 2016
Ibrutinib inhibits pre-BCR<sup>+</sup> B-cell acute lymphoblastic leukemia progression by targeting BTK and BLKEkaterina Kim, Christian Hurtz, Stefan Koehrer, et al.
Pageof 23